OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
January 02, 2017
FDA plans to advance initiatives for ensuring reliable production of drugs and biologics in 2017.
December 19, 2016
A pilot project, beginning in 2017, will support the development of biosimilars.
December 16, 2016
Univercells received a grant from the Bill & Melinda Gates Foundation for the development of a vaccine manufacturing platform.
December 15, 2016
Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.
GlaxoSmithKline opened a new vaccines R&D center in Rockville, MD creating up to 200 new jobs.
December 07, 2016
Principles of dissolution testing, including method development and testing apparatus, are reviewed.
December 05, 2016
FDA and BARDA awarded a contract to Continuus Pharmaceuticals to develop an end-to-end continuous manufacturing process for solid-dosage drugs.
December 02, 2016
Quantitative and qualitative tools allow better understanding of mixing in a single-use bioprocessing system.
Hot-melt coating was used to develop taste-masked orally disintegrating granules of acetaminophen and caffeine.
November 30, 2016
Takeda will invest more than 100 million Euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany.